Leo Pharma

Entity type image
Type: Company
Name: Leo Pharma
Web Address: http://www.leo.se
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Coffee break with... Antonia Moutafis

Lord Pinching of Maxwell House meets Greek Goddess, Pf cover girl and Leo Pharma legend, Antonia Moutafis, for another caffeine-laced study of the human condition.I turn off the M5 in Bristol, alight from my vehicle and take custody of two comfortable ... [Published Pharma Field - 3 hours ago]
First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

LEO Pharma AS - Strategic SWOT Analysis Review - new company profile report

LEO Pharma A/S (LEO Pharma) is a research-based pharmaceutical company. It undertakes the discovery, development, manufacture and commercialization of pharmaceuticals for the treatment of diseases in the areas of dermatology and thrombosis. The company ... [Published TransWorldNews - Apr 19 2013]
First reported Mar 04 2013 - Updated Mar 04 2013 - 1 reports
Élan Corporation plc
Élan Corporation plc

Deals Of The Week: Elan Takes It All Off, Attracts Suitors

Elan Corp. PLC has been engaged in a slow motion strip-tease over the past five years; it has now shed so many assets that it may soon disappear entirely. On Feb. 25, Royalty Pharma fielded an $11/share, $6.5 billion bid for the company . That was ... [Published The IN VIVO Blog - Mar 04 2013]
First reported Feb 26 2013 - Updated Feb 26 2013 - 1 reports

4SC Discovery And LEO Pharma Announce Exclusive Research And License Agreement For Inflammatory Skin Diseases

Sorry, there is a problem with our siteThe page you have requested cannot be displayedThis occurrence has been logged for quality assurance purposes. ... [Published Bioresearch Online - Feb 26 2013]
Entities: Leo Pharma
First reported Feb 20 2013 - Updated Feb 20 2013 - 1 reports

DOVONEX (Calcipotriene) Cream [LEO Pharma Inc.]

Updated Date: Feb 20, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 20 2013]
First reported Feb 19 2013 - Updated Feb 19 2013 - 1 reports

DOVONEX (Calcipotriene) Cream [LEO Pharma Inc.]

Updated Date: Feb 19, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 19 2013]
First reported Dec 19 2012 - Updated Dec 20 2012 - 3 reports

TACLONEX (Calcipotriene And Betamethasone Dipropionate) Ointment [LEO Pharma Inc.]

Updated Date: Dec 19, 2012 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Dec 20 2012]

Quotes

"The initiation of this Phase 1 trial with VBY-036 represents another significant development objective for Virobay" stated Robert Booth
Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neur ... [Published Street Insider - May 23 2013]
...Ulrik de Lichtenberg, head of research informatics and data management at LEO Pharma. "We have extended the functionality of the core ELN product by leveraging the Accelrys Enterprise Platform to create an electronic process exactly matched to our scientific workflows. The ELN platform has strengthened our internal knowledge sharing, and at the same time provided us with a seamless process for capturing documentation needed to obtain and defend patents."
New Release of Accelrys Electronic Lab Notebook Transforms Laboratory Operations [Published ADVFN India - May 20 2013]
(Logo: http://photos.prnewswire.com/prnh/20130221/595427 ) "Patienter har en unik indsigt i deres sygdom. Derfor involverer vi patienter som aktive deltagere i vores innovationsproces. Med henblik på at gøre en forskel i dagligdagen hos personer med hudsygdomme ønsker vi at få en forståelse af deres udfordringer - og arbejde sammen om at finde løsninger" , udtaler Kim Kjøller, Senior Vice President Global Development, LEO Pharma
LEO Pharma sætter patienter i centrum for innovation [Published PR Newswire - Mar 19 2013]
Kim Kjoeller, vice-presidente sênior de desenvolvimento global da LEO Pharma, afirmou: "A LEO Pharma está feliz com o acordo com a 4SC e com as possibilidades que ele oferece aos pacientes. O composto possui o potencial para erradicar completamente os sintomas da psoríase, liberando as pessoas do fardo dessa doença de pele crônica. A LEO Pharma esforça-se para ampliar e melhorar constantemente as opções de tratamento para os pacientes, e esse último acordo é o exemplo perfeito do nosso compromisso para atender as necessidades dos pacientes com terapias novas e inovadoras"
LEO Pharma e 4SC Discovery anunciam contrato de pesquisa e licença exclusivo [Published PR Newswire - Feb 26 2013]

More Content

All (42) | News (12) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (0) | Press Releases (23)
sort by: Date | Relevance
Coffee break with... Antonia Moutafis [Published Pharma Field - 3 hours ago]
Virobay, Inc. initiates a Phase 1 Trial of VBY-... [Published Street Insider - May 23 2013]
Virobay, Inc. Initiates A Phase 1 Trial Of VBY-... [Published TheStreet.com - May 23 2013]
Virobay, Inc. initiates a Phase 1 Trial of VBY-... [Published Michigan Live - May 23 2013]
Virobay, Inc. initiates a Phase 1 Trial of VBY-... [Published PR Newswire - May 23 2013]
Is less more in a paperless laboratory? [Published Scientific Computing World - May 20 2013]
New Release of Accelrys Electronic Lab Notebook... [Published ADVFN India - May 20 2013]
Council tells residents ditches are up to them [Published Kelowna Daily Courier - May 15 2013]
LEO Pharma AS - Strategic SWOT Analysis Review ... [Published TransWorldNews - Apr 19 2013]
LEO Pharma place les patients au cœur de l'inno... [Published PR Newswire - Mar 19 2013]
LEO Pharma sætter patienter i centrum for innov... [Published PR Newswire - Mar 19 2013]
Bei LEO Pharma stehen Patienten im Mittelpunkt ... [Published PR Newswire: Health - Mar 19 2013]
LEO Pharma place les patients au cœur de l'inno... [Published PR Newswire: Health - Mar 19 2013]
LEO Pharma pone a los pacientes en el centro de... [Published PR Newswire: Health - Mar 19 2013]
LEO Pharma Puts Patients at the Heart of Innova... [Published PR Newswire: Health - Mar 19 2013]
LEO Pharma Puts Patients at the Heart of Innova... [Published PR Newswire: Health - Mar 19 2013]
LEO Pharma Pone a Pacientes en el Centro de la ... [Published Financial Services - Mar 19 2013]
LEO Pharma coloca pacientes no coração da inovação [Published Financial Services - Mar 19 2013]
Virobay and LEO Pharma Initiate a Phase 1 Trial... [Published PR Newswire: Health - Mar 18 2013]
Virobay and LEO Pharma Initiate a Phase 1 Trial... [Published PR Newswire: Health - Mar 18 2013]
Research and Markets: Dermatitis Global Clinica... [Published Yahoo! Finance - Mar 05 2013]
Deals Of The Week: Elan Takes It All Off, Attra... [Published The IN VIVO Blog - Mar 04 2013]
4SC Discovery And LEO Pharma Announce Exclusive... [Published Bioresearch Online - Feb 26 2013]
LEO Pharma y 4SC Discovery anuncian un acuerdo ... [Published Financial Services - Feb 26 2013]
LEO Pharma and 4SC Discovery Announce Exclusive... [Published Financial Services - Feb 26 2013]
LEO Pharma e 4SC Discovery anunciam contrato de... [Published PR Newswire - Feb 26 2013]
LEO Pharma y 4SC Discovery anuncian acuerdo exc... [Published PR Newswire - Feb 26 2013]
LEO Pharma and 4SC Discovery Announce Exclusive... [Published PR Newswire: Financial Services - Feb 26 2013]
LEO Pharma und 4SC Discovery geben exklusives F... [Published Financial Services - Feb 26 2013]
LEO Pharma et 4SC Discovery annoncent un contra... [Published Financial Services - Feb 26 2013]
1 2
In Focus
  •  
Robert Booth, Freddy Svane, Christian Hansen, [more]
  •  
4SC AG, Élan Corporation plc, Accelrys Inc, [more]
  •  
University of Athens, University of Birmingham, Statens Serum Institut, [more]
  •  
Calcipotriene, Psoriasis, Dovonex, [more]
  •  
Taclonex, Betamethasone Dipropionate, Tysabri, [more]
  •  
Bristol, Menlo Park, Hyderabad (Andhra Pradesh, India), [more]
  •  
Denmark, Germany, Greece, [more]
  •  
Diseases, Medication, Research & Development, [more]
  •  
Health, Pharma & Biotech
PR Newswire, PR Newswire: Health, Financial Services, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Deals Of The Week: Elan Takes It All Off, Attra... [Published The IN VIVO Blog - Mar 04 2013]
Elan Corp. PLC has been engaged in a slow motion strip-tease over the past five years; it has now shed so many assets that it may soon disappear entirely. On Feb. 25, Royalty Pharma fielded an $11/share, $6.5 billion bid for the company . That was ...
DOVONEX (Calcipotriene) Cream [LEO Pharma Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Feb 20 2013]
Updated Date: Feb 20, 2013 EST ...
DOVONEX (Calcipotriene) Cream [LEO Pharma Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Feb 19 2013]
Updated Date: Feb 19, 2013 EST ...
A Big Year for Novel Drugs Approvals [Published I Am Biotech - Jan 17 2013]
What was your top Biopharma highlight for 2012? If it wasn’t the stellar move in the AMEX Biotech Index (up 42%), or the reauthorization of PDUFA, then perhaps it was the decade high for innovative drugs approvals. We would need to go back to the 1990s ...
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Dec 20 2012]
Updated Date: Dec 19, 2012 EST ...
1 2

Press Releases

sort by: Date | Relevance
Virobay, Inc. initiates a Phase 1 Trial of VBY-... [Published PR Newswire - May 23 2013]
LEO Pharma place les patients au cœur de l'inno... [Published PR Newswire - Mar 19 2013]
LEO Pharma sætter patienter i centrum for innov... [Published PR Newswire - Mar 19 2013]
Bei LEO Pharma stehen Patienten im Mittelpunkt ... [Published PR Newswire: Health - Mar 19 2013]
LEO Pharma place les patients au cœur de l'inno... [Published PR Newswire: Health - Mar 19 2013]
1 2 3 4 5
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.